当前位置：药药网 / 药品研发 / 美国药品上市后承诺数据库
Gardasil 9, Human Papillomavirus 9-valent Vaccine, Recombinant
申请企业
Merck Sharp & Dohme Corp.
药品名称
Gardasil 9, Human Papillomavirus 9-valent Vaccine, Recombinant
承诺描述
To conduct Study V503-049 to evaluate the efficacy of a three-dose regimen of GARDASIL®9 in the prevention of oral persistent infection with HPV types 16, 18, 31, 33, 45, 52 or 58 in men 20 through 45 years of age.